899 related articles for article (PubMed ID: 11228049)
21. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
[TBL] [Abstract][Full Text] [Related]
22. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
Imai Y; Clemmons DR
Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
24. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
25. Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells.
Kuo YH; Chen TT
Exp Cell Res; 2002 Oct; 280(1):75-89. PubMed ID: 12372341
[TBL] [Abstract][Full Text] [Related]
26. Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation.
Sarbassov DD; Peterson CA
Mol Endocrinol; 1998 Dec; 12(12):1870-8. PubMed ID: 9849961
[TBL] [Abstract][Full Text] [Related]
27. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes.
Boney CM; Gruppuso PA; Faris RA; Frackelton AR
Mol Endocrinol; 2000 Jun; 14(6):805-13. PubMed ID: 10847583
[TBL] [Abstract][Full Text] [Related]
28. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
Gryz EA; Meakin SO
Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
[TBL] [Abstract][Full Text] [Related]
29. IGF-I increases IGFBP-5 and collagen alpha1(I) mRNAs by the MAPK pathway in rat intestinal smooth muscle cells.
Xin X; Hou YT; Li L; Schmiedlin-Ren P; Christman GM; Cheng HL; Bitar KN; Zimmermann EM
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G777-83. PubMed ID: 15068962
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways.
Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ
Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789
[TBL] [Abstract][Full Text] [Related]
31. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I.
Suzuki K; Takahashi K
Biochem Biophys Res Commun; 2000 May; 272(1):111-5. PubMed ID: 10872812
[TBL] [Abstract][Full Text] [Related]
32. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
33. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.
Motegi A; Fujimoto J; Kotani M; Sakuraba H; Yamamoto T
J Cell Sci; 2004 Jul; 117(Pt 15):3319-29. PubMed ID: 15226403
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
[TBL] [Abstract][Full Text] [Related]
35. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor.
Navarro M; Baserga R
Endocrinology; 2001 Mar; 142(3):1073-81. PubMed ID: 11181521
[TBL] [Abstract][Full Text] [Related]
36. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
37. Insulin-like growth factor I synergizes with interleukin 4 for hematopoietic cell proliferation independent of insulin receptor substrate expression.
Soon L; Flechner L; Gutkind JS; Wang LH; Baserga R; Pierce JH; Li W
Mol Cell Biol; 1999 May; 19(5):3816-28. PubMed ID: 10207105
[TBL] [Abstract][Full Text] [Related]
38. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
39. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
